Visitors can see how Accumold is using advanced micro-moulding solutions to enable the development of next-generation medical devices and components across the health sector.
Commitment to Supporting Medical Device Evolution
“Our presence at MD&M East reflects our commitment to supporting the rapid evolution of the medical device industry,” says Brett Saddoris, technical sales manager at Accumold. “We thrive on helping engineers and designers turn bold ideas into manufacturable realities — whether they’re prototyping disruptive technologies or ramping up to high-volume production.”
Breakthrough in High-Volume Micro Injection Moulding
Among the company’s latest innovations is its breakthrough in high-volume micro injection moulding of thin-walled cannulas. Historically produced through extrusion and labour-intensive secondary processes, cannulas with extremely thin walls are now being moulded in a single step — eliminating inconsistencies, improving structural integrity, and enabling annual production volumes of up to 40 million parts per cell.
Significant Leap Forward in Medical Manufacturing
“The ability to reliably mold cannulas with wall thicknesses as low as 0.004 inches represents a significant leap forward in medical manufacturing,” Saddoris explains. “This process reduces part variability, increases production efficiency, and opens up exciting new design possibilities for minimally invasive medical devices.”
Visit Accumold at MD&M East
Visitors to Booth 551 at MD&M East will have the opportunity to meet Accumold’s technical team and view samples of moulded parts.
